November 24, 2015

Eli Lilly and Co.’s Petrazza in a trial extended the lives of patients who took the drug in combination with two forms of chemotherapy to 11.5 months. 

November 24, 2015

Following Monday’s announcement that Pfizer would be merging with Ireland-based company Allergan, some analysts are predicting that Pfizer would split the combined company following the $160 billion deal, Reuters reported. According to the report, the split would likely divide the company’s established products (i.e., generics) unit and its innovative medicines unit, composed of drugs that are still patent-protected. (Reuters)

November 23, 2015

The new indication provides another option for the estimated 300,000 patients who will undergo hip replacements in a year. 

November 23, 2015

CVS Health has opted to only offer one of the two new PCSK9 inhibitors on its CVS/caremark commercial formularies. 

November 23, 2015

The FDA has approved Bristol-Myers Squibb’s Opdivo as a treatment for renal cell carcinoma in some patients. 

November 23, 2015

Mylan has rolled out its MyFreshStart online tool for patients with hypertension taking Mavik in an effort to increase adherence among them. 

November 23, 2015

Perrigo is buying a Crohn’s disease treatment from AstraZeneca. 

November 23, 2015

A 15-member board composed will govern the combined company and Pfizer CEO Ian Read will be CEO of the combined company and Allergan CEO Brent Saunders will be the president and COO. 

November 20, 2015

Specialty medications represent only 1% of all prescriptions but, in 2014, these medications resulted in over 31% of all drug spending.

November 20, 2015

In preparation for this launch, Mission has expanded its sales force and increased promotional efforts to reach more primary care and internal medicine healthcare providers.

November 20, 2015

Mylan's acquisition of Jai Pharma brings Mylan a broad women's care portfolio, strong technical capabilities and dedicated hormone manufacturing. 

November 20, 2015

With the U.S. Treasury announcing plans to crack down on tax-inversion deals on Thursday, pharmaceutical giants Pfizer and Allergen have accelerated their merger talks, according to reports. The potential $150 billion deal could see Pfizer redomicile in Ireland. (Reuters)

November 19, 2015

The Food and Drug Administration has approved Narcan, a nasal spray dose of naloxone, which is typically administered via injection. 

November 19, 2015

The healthcare logistics industry has seen significant improvements in product security and regulatory compliance across the supply chain. 

November 18, 2015

Steven Collis has served as president and CEO of AmerisourceBergen since July 2011 and a director since May 2011.

November 18, 2015
The dispensing rate of generic medicines will increase from 88% to as high as 92% by 2020, the IMS Institute for Healthcare Informatics reported
 
November 16, 2015

The drug is meant to be used on-demand to control bleeding episodes and as a way to reduce their frequency.

November 13, 2015
The drug was granted Fast Track, Breakthrough, Priority Review and Accelerated Approval status by the FDA and has shown an objective response rate of 59% with a median duration of about 12.4 months. 
November 13, 2015

Perrigo’s shareholders did not tender a majority of the company’s shares to Mylan by 8 a.m. EST Friday, effectively ending Mylan’s acquisition attempt. 

November 13, 2015

AtlanticLIVE’s event, “The Diabetes Divide,” addressed an issue that affects an estimated 415 million people worldwide. 

November 11, 2015

A new drug has been approved that, in conjunction with vemurafenib, is meant to treat metastatic melanoma that can't be removed through surgery with a certain gene mutation. 

November 11, 2015

As 2015 draws to a close, the year is on track to be one in which the value of the branded drugs losing their patent protection approaches an all-time high. The dozens of drugs that will have lost their patent protection this year are estimated to have global sales of $44 billion a year — the highest total since $53 billion worth of medications went off patent in 2012.

November 9, 2015

GlaxoSmithKline is celebrating 300 years. Originating as a small pharmacy in East London in 1715, GlaxoSmithKline has grown into the sixth largest global pharmaceutical company, the International Business Times reported Monday. "I'm extremely proud of all the history we have behind us," noted Nikki Yakes, GSK UK Pharma general manager. "It is a quite remarkable achievement to be able to trace our roots back to one young entrepreneur in 1715." (International Business Times)

November 6, 2015

Based on the company’s presentation accompanying a conference call on the acquisition, AstraZeneca’s focus to be on the treatment ZS Pharma is developing for hyperkalemia, a side effect of chronic kidney disease,